| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(80)91498-1 |
| P698 | PubMed publication ID | 6103391 |
| P2093 | author name string | S G Thompson | |
| T W Meade | |||
| R Chakrabarti | |||
| A P Haines | |||
| W R North | |||
| Y Stirling | |||
| M Brozovié | |||
| P2860 | cites work | Resistance to arteriosclerosis in pigs with von Willebrand's disease. Spontaneous and high cholesterol diet-induced arteriosclerosis | Q24594413 |
| Ethnic group comparisons of variables associated with ischaemic heart disease | Q36807345 | ||
| Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen | Q39459157 | ||
| Role of endothelium in sequestration of lipoprotein and firbrinogen in aortic lesions, thrombi, and graft pseudo-intimas | Q39568898 | ||
| Biochemistry of blood coagulation | Q39708051 | ||
| Physiological mechanisms in coagulation and fibrinolysis | Q39708066 | ||
| Population-based distributions of haemostatic variables | Q39708097 | ||
| Relationships Between Platelets and Coagulation Factors in Hemostasis | Q39722730 | ||
| Coronary heart disease mortality among Seventh-Day Adventists with differing dietary habits: a preliminary report | Q46180647 | ||
| Factor VII during Warfarin Treatment | Q47823756 | ||
| Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations | Q66904521 | ||
| Haemostatic variables associated with diabetes and its complications | Q66971398 | ||
| Frequency of alcohol consumption and morbidity and mortality: The Yugoslavia Cardiovascular Disease Study | Q72421343 | ||
| Recent history of coronary disease | Q75607773 | ||
| P433 | issue | 8177 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1050-1054 | |
| P577 | publication date | 1980-05-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Haemostatic function and cardiovascular death: early results of a prospective study | |
| P478 | volume | 1 |
| Q37202358 | A critical review of the relationship between impaired fibrinolysis and myocardial infarction |
| Q69005885 | A genetic marker for systemic amyloidosis in juvenile arthritis |
| Q33686198 | A randomised controlled trial to investigate the effect of a high fibre diet on blood pressure and plasma fibrinogen |
| Q40854366 | Activated and total coagulation factor VII, and fibrinogen in coronary artery disease |
| Q37156874 | Acute phase reactants as novel predictors of cardiovascular disease |
| Q59326346 | Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis |
| Q33949687 | An association between clotting factor VII and carotid intima-media thickness: the CARDIA study |
| Q34740263 | Analysis of risk factors of ST-segment elevation myocardial infarction in young patients |
| Q72451354 | Anticoagulants in coronary heart disease--retrospect and prospect |
| Q33888171 | Antithrombotic and prothrombotic activities of the vascular endothelium |
| Q40430415 | Arterial thrombosis for the clinician. Pathobiology and emerging concepts. |
| Q72932153 | Assay, kinetics and properties of plasma adenosine diphosphatase. The relationship to acid and alkaline phosphatase and variations in disease |
| Q43919582 | Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study). |
| Q47373856 | Associations of plasma fibrinogen assays, C-reactive protein and interleukin-6 with previous myocardial infarction |
| Q42620508 | Biostatistical evidence for two distinct chronic open angle glaucoma populations |
| Q68193866 | Blood coagulability and fibrinolytic activity before and after physical training during the recovery phase of acute myocardial infarction |
| Q46174197 | Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis |
| Q51623641 | Blood glucose may condition factor VII levels in diabetic and normal subjects. |
| Q39697000 | Blood rheology in general medicine and surgery |
| Q34492133 | Catching up the Europeans in preventing heart disease. |
| Q44724818 | Characterization of a tissue factor/factor VIIa-dependent model of thrombosis in hypercholesterolemic rabbits |
| Q35633523 | Cholesterol and lipoproteins: beyond atherogenesis |
| Q43164515 | Circulating markers of arterial thrombosis and late-stage age-related macular degeneration: a case-control study |
| Q38255357 | Clinical disorders of fibrinolysis: a critical review |
| Q33261887 | Cloning of human hepatic nuclear factor 1 (HNF1) and chromosomal localization of its gene in man and mouse |
| Q71993564 | Coagulation Activation in Type 2 Diabetes Mellitus: the Higher Coronary Risk of Female Diabetic Patients |
| Q69882249 | Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels |
| Q68979219 | Conservative drug therapy and walking exercise in stage IIb peripheral arterial occlusion disease |
| Q33326452 | Contrasting Fibrinolytic Responses in Type 1 (Insulin-dependent) and Type 2 (Non-insulin-dependent) Diabetes |
| Q36756073 | Coronary artery disease and haemostatic variables in heterozygous familial hypercholesterolaemia |
| Q41303111 | Coronary artery disease in severe haemophilia |
| Q72452919 | Coronary heart disease, fibrinogen, and plasma heparin neutralising activity |
| Q36679823 | Corticosteroids: do they damage the cardiovascular system? |
| Q42020555 | Determinants of disease and disability in the elderly: The Rotterdam elderly study |
| Q33684907 | Determinants of plasma lipoproteins and coagulation factors in men from Caerphilly, South Wales |
| Q72452900 | Diagnostic problems in unilateral proptosis |
| Q72962790 | Dietary determinants of lipoproteins, total cholesterol, viscosity, fibrinogen, and blood pressure |
| Q44610787 | Dietary fatty acids and blood coagulation |
| Q41143875 | Effect of high-fibre diet on haemostatic variables in diabetes |
| Q71354800 | Effect of treatment of hyperlipidaemia on haemostatic variables |
| Q43596151 | Effect on plasma fibrinogen of hypercholesterolaemia treatment with pravastatin |
| Q52533093 | Effects of lipids and lipoproteins on thrombosis and rheology. |
| Q69268043 | Effects of oestrogen therapy and orchidectomy on coagulation and prostanoid synthesis in patients with prostatic cancer |
| Q38580592 | Effects of progestogens on the cardiovascular system. |
| Q72005553 | Effects of warfarin therapy on plasma fibrinogen, von Willebrand factor, and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysms |
| Q72477513 | Efficacy of anticoagulation in the U.K |
| Q67762199 | Elevation of factor VII activity and mass in coronary artery disease of varying severity |
| Q34489552 | Epidemiological characteristics of platelet aggregability. |
| Q36489468 | Erythrocyte rheology |
| Q28276648 | Estrogen in patients with prostatic cancer. An assessment of the risks and benefits |
| Q25256604 | Exclusion and inclusion of nonwhite ethnic minority groups in 72 North American and European cardiovascular cohort studies |
| Q35200124 | Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level |
| Q34048881 | Familial hypercholesterolaemia as an example of early diagnosis of coronary artery disease risk by DNA techniques |
| Q35224492 | Fibrin and Its Derivatives in the Normal and Diseased Vessel Wall |
| Q92710708 | Fibrin(ogen) in human disease: both friend and foe |
| Q43162739 | Fibrinogen |
| Q72049303 | Fibrinogen and Silent Atherosclerosis in Subjects With Cardiovascular Risk Factors |
| Q37201947 | Fibrinogen and cardiovascular disease |
| Q39461091 | Fibrinogen and fibrin: biochemistry and pathophysiology |
| Q35729527 | Fibrinogen and mechanisms of thrombosis. A difficult link |
| Q40492595 | Fibrinogen in Human Atherosclerosis |
| Q41094038 | Fibrinogen levels and exercise. Is there a relationship? |
| Q72452911 | Fibrinogen, coronary heart disease and prospective studies |
| Q34488611 | Fibrinogen: a possible link between social class and coronary heart disease |
| Q40406437 | Fibrinolysis and atherosclerosis |
| Q72586948 | Fibrinopeptide A and sudden coronary death |
| Q34998383 | Fibulin-1 and fibrinogen in human atherosclerotic lesions |
| Q67555231 | Generation of thrombin activity in relation to factor VIII:C concentrations and vascular complications in type 1 (insulin-dependent) diabetes mellitus |
| Q73295903 | Genetic Modulation of Plasma Fibrinogen Concentrations: Possible Importance of Interleukin-6 |
| Q47391741 | Genetic and cultural inheritance of plasma fibrinogen concentration |
| Q34554267 | HDL and arteriosclerosis: beyond reverse cholesterol transport |
| Q39338214 | Haematological stress syndrome in atherosclerosis |
| Q36757211 | Haemostatic factors and ischaemic heart disease. The Caerphilly study |
| Q72471293 | Haemostatic factors in human aortic intima |
| Q72477520 | Haemostatic function and ischaemic heart disease |
| Q69886150 | Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study |
| Q34036695 | Haemostatic function in myocardial infarction |
| Q40582669 | Haemostatic function, arterial disease and the prevention of arterial thrombosis |
| Q50617171 | Haemostatic variables in phenylketonuric children under dietary treatment. |
| Q68407646 | Haemostatic variables, serum lipid abnormalities and vascular complications in diabetes mellitus: a 5 year follow-up study |
| Q44818970 | HbA1c and serum fructosamine in diabetic patients: Relationship to age, clotting and fibrinolysis parameters and urinary microalbumin excretion |
| Q41675668 | Hemostatic concomitants of syndrome X |
| Q51562558 | Hemostatic factors in hypertriglyceridemic men: effects of a fatty meal before and after triglyceride-lowering treatment with etofibrate. |
| Q69859402 | High-density lipoprotein composition is altered by a common DNA polymorphism adjacent to apoprotein AII gene in man |
| Q42186702 | Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin |
| Q41308154 | Hypercoagulability and coronary artery disease |
| Q43833280 | Hyperglycemia induces PAI-1 gene expression in adipose tissue by activation of the hexosamine biosynthetic pathway |
| Q51647241 | Hypertriglyceridaemia and hypercoagulability |
| Q37786770 | Hypertriglyceridaemia, triglyceride-rich lipoproteins and coronary heart disease |
| Q36820491 | Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment |
| Q73295895 | Influence of Contraceptive Pill Use, Premenopause and Postmenopausal State on Hemostatic Parameters in Ethnic Chinese Women |
| Q42122781 | Influence of power and aerobic exercise training on haemostatic factors after coronary artery surgery |
| Q72593264 | Interpretation of clofibrate trial |
| Q68731356 | Investigations into a vascular etiology for low-tension glaucoma |
| Q36623260 | Isolation and characterisation of cDNA clones for the A alpha- and gamma-chains of human fibrinogen |
| Q43379861 | Lipid peroxides and atherosclerosis |
| Q41106629 | Low dietary intake of linoleic acid predisposes to myocardial infarction. |
| Q41208114 | Markers of disease severity in peripheral atherosclerosis |
| Q73438239 | Markers of risk in young offspring with paternal history of myocardial infarction |
| Q44770881 | Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk? |
| Q52874727 | Metformin Causes a Reduction in Basal and Post-venous Occlusion Plasminogen Activator Inhibitor-1 in Type 2 Diabetic Patients |
| Q35209410 | Mode of action of fibrates |
| Q42040417 | Monoclonal antibodies to human factor VII: production of immunodepleted plasma for VII:C assays |
| Q50534746 | Natural anticoagulants, aging, and thromboembolism. |
| Q51471544 | Near-site monitoring of the antiplatelet drug abciximab using the Hemodyne analyzer and modified thrombelastograph. |
| Q34255686 | Niacin: another look at an underutilized lipid-lowering medication |
| Q38053120 | Obstructive sleep apnea syndrome: blood viscosity, blood coagulation abnormalities, and early atherosclerosis |
| Q35781139 | Obstructive sleep apnoea and stroke |
| Q71593348 | Oral contraceptives, clotting factors, and thrombosis |
| Q72159919 | Pathologic fibrin formation and cold-induced clotting of membrane oxygenators during cardiopulmonary bypass |
| Q41047270 | Pathophysiology and inflammatory aspects of plaque rupture |
| Q71129084 | Pathophysiology of coronary artery disease |
| Q34071231 | Phobic anxiety and ischaemic heart disease |
| Q40737304 | Physical activity and lipoprotein lipid disorders |
| Q41705011 | Plasma fibrinogen and its correlates in elderly Japanese men living in Japan and Hawaii |
| Q41879314 | Plasma fibrinogen--a major coronary risk factor |
| Q70322551 | Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations |
| Q39492304 | Platelet inhibition with Ticlopidine in atherosclerotic intermittent claudication |
| Q71669232 | Prevention of coronary heart disease. Summary of a conference held at St. Thomas's Hospital, London, in June 1982 |
| Q78192649 | Primary stenting in acute myocardial infarction: influence of diabetes mellitus in angiographic results and clinical outcome |
| Q34777748 | Prostaglandins in vascular disease: a seminal approach. |
| Q42108295 | Protein C values in coronary artery disease |
| Q51662741 | Protein S declines during winter respiratory infections. |
| Q35378987 | Psychological characteristics and fatal ischaemic heart disease |
| Q30912640 | Recent advances in ischaemic heart disease. |
| Q33610696 | Reduction of factor VII coagulant activity (VIIC), a risk factor for ischaemic heart disease, by fixed dose warfarin: a double blind crossover study |
| Q33379174 | Review of Hypercoagulability Syndromes: What the Interventionalist Needs to Know |
| Q41887737 | Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations |
| Q64130874 | Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction: findings from National Health and Nutrition Examination Survey III |
| Q72096187 | Serum Total Sialic Acid and Lipid-Associated Sialic Acid in Normal Individuals and Patients with Myocardial Infarction, and Their Relationship to Acute Phase Proteins |
| Q35178190 | Serum sialic acid concentration and cardiovascular mortality |
| Q92164140 | Sighting acute myocardial infarction through platelet gene expression |
| Q73512084 | Sleep-disordered breathing and stroke |
| Q41830774 | Some long term effects of smoking on the haemostatic system: a report from the Caerphilly and Speedwell Collaborative Surveys |
| Q33611938 | Strenuous exercise, plasma fibrinogen, and factor VII activity |
| Q73012028 | Swimming and hemostasis during rehabilitation in patients with coronary heart disease |
| Q52584483 | The 95RGD97 sequence on the Aα chain of fibrinogen is essential for binding to its erythrocyte receptor. |
| Q42465243 | The effect of number of days in culture and plasminogen activator inhibitor-1 (PAI-1) 4G/5G genotype on PAI-1 antigen release by cultured human umbilical vein endothelial cells |
| Q40192020 | The extrinsic system. |
| Q72650920 | The fibrinolytic response to stanozolol in normal subjects |
| Q70673797 | The identification of a DNA polymorphism of the alpha fibrinogen gene, and the regional assignment of the human fibrinogen genes to 4q26-qter |
| Q44010976 | The impact of angiotensin II receptor blockade and the DASH diet on markers of endogenous fibrinolysis |
| Q67900735 | The natural anticoagulant protein S is decreased in male smokers |
| Q77181781 | The response of serum sialic acid and other acute phase reactants to an oral fat load in healthy humans |
| Q34340559 | The role of fat cell derived peptides in age-related metabolic alterations |
| Q36785774 | Theory and practice in prevention of arterial thrombosis |
| Q42979228 | Thrombin and plasmin activity in coronary artery disease |
| Q42684656 | Thrombin generation and activation of the thrombomodulin protein C system in open heart surgery depend on the underlying cardiac disease |
| Q71434187 | Thrombophilia in patients with hypercholesterolemia |
| Q41309558 | Thrombosis and ischaemic heart disease |
| Q28138375 | Time for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteral estrogen regimen |
| Q37611155 | Total and lipid bound sialic acid levels in patients with polycystic ovary syndrome |
| Q38127353 | Treating thrombus in the coronary arteries |
| Q38865147 | Trends in coronary artery disease and associated risk factors in sub-Saharan Africans |
| Q36683565 | Triglycerides and disease. |
| Q41994945 | Turnover of factor X and of prothrombin in rabbits fed on a standard or cholesterol-supplemented diet |
| Q38274957 | Vascular effects of the Mediterranean diet part I: anti-hypertensive and anti-thrombotic effects |
| Q57241683 | What determines mortality risk in male former cigarette smokers? |
| Q73315343 | [Cardiovascular risk factors in diabetic nephropathy] |
Search more.